Amendment No. 2 to Schedule 13D for KALA BIO, Inc.

This Amendment No. 2 to Schedule 13D, filed by SR One Capital Fund II Aggregator, LP, SR One Capital Partners II, LP, SR One Capital Management, LLC, and Simeon George, M.D., updates the ownership details of KALA BIO, Inc.'s Common Stock. On October 7, 2025, Aggregator converted 4,110 shares of Series H Preferred Stock into 411,000 shares of Common Stock. Subsequently, on October 14, 2025, Aggregator sold 66,824 shares of Common Stock in open market transactions. As of October 14, 2025, the Reporting Persons collectively own 344,176 shares, representing 4.6% of the outstanding Common Stock. The filing also includes details of transactions since the previous amendment and disclaims any present plans for further corporate actions.